Endocrine gland neoplasm
MONDO:0002082A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.
Also known as: endocrine gland neoplasm (disease), endocrine gland tumor, endocrine gland tumour, endocrine neoplasm, endocrine system neoplasm, endocrine system tumor, endocrine system tumour, endocrine tumor
4608 clinical trials for this condition and its sub-types, 8 tagged with Endocrine gland neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Endocrine gland neoplasm
-
Malignant endocrine neoplasm 17 trials · 2,932 incl. sub-types
16 sub-types
- Liver cancer 255 trials · 1,708 incl. sub-types Sub-types →
- Neuroendocrine carcinoma 106 trials · 744 incl. sub-types Sub-types →
- Thyroid cancer 166 trials · 328 incl. sub-types Sub-types →
- Thymus cancer 10 trials · 225 incl. sub-types Sub-types →
- Adrenal gland cancer 16 trials · 62 incl. sub-types Sub-types →
- Pineal gland cancer 0 trials · 19 incl. sub-types Sub-types →
- Malignant tumor of parathyroid gland 2 trials · 6 incl. sub-types Sub-types →
- Maligant granulosa cell tumor of ovary 5 trials
- Pituitary cancer 2 trials · 4 incl. sub-types Sub-types →
- Ovarian neuroendocrine neoplasm 0 trials · 2 incl. sub-types Sub-types →
- High-grade neuroendocrine carcinoma of the corpus uteri 0 trials
- Low-grade neuroendocrine tumor of the corpus uteri 0 trials
- Malignant carotid body paraganglioma 0 trials
- Malignant jugulotympanic paraganglioma 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Liver and intrahepatic bile duct neoplasm 78 trials · 1,752 incl. sub-types
17 sub-types
- Liver cancer 255 trials · 1,708 incl. sub-types Sub-types →
- Biliary tract neoplasm 31 trials · 627 incl. sub-types Sub-types →
- Liver hemangioma 6 trials Sub-types →
- Undifferentiated embryonal sarcoma of the liver 6 trials
- Hepatocellular adenoma 2 trials Sub-types →
- Fibrohistiocytic inflammatory pseudotumor of the liver 0 trials
- Hepatic angiomyolipoma 0 trials
- Hepatic granuloma 0 trials
- Inflammatory pseudotumor of the liver 0 trials
- Liver adenomatosis 0 trials
- Liver inflammatory myofibroblastic tumor 0 trials
- Liver leiomyoma 0 trials Sub-types →
- Liver lipoma 0 trials Sub-types →
- Liver mesenchymal hamartoma 0 trials
- Liver solitary fibrous tumor 0 trials
- Lymphoplasmacytic inflammatory pseudotumor of the liver 0 trials
- Solitary necrotic nodule of the liver 0 trials
-
Neuroendocrine neoplasm 181 trials · 985 incl. sub-types
14 sub-types
- Neuroendocrine carcinoma 106 trials · 744 incl. sub-types Sub-types →
- Lung neuroendocrine neoplasm 21 trials · 540 incl. sub-types Sub-types →
- Digestive system neuroendocrine neoplasm 52 trials · 167 incl. sub-types Sub-types →
- Paraganglioma 53 trials · 57 incl. sub-types Sub-types →
- Carcinoid tumor 33 trials · 47 incl. sub-types Sub-types →
- Prostate neuroendocrine neoplasm 20 trials · 25 incl. sub-types Sub-types →
- Hereditary pheochromocytoma-paraganglioma 6 trials Sub-types →
- Thymic neuroendocrine tumor 3 trials · 6 incl. sub-types Sub-types →
- Bronchial endocrine tumor 4 trials
- Ovarian neuroendocrine neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Breast neuroendocrine neoplasm 0 trials Sub-types →
- Laryngeal neuroendocrine neoplasm 0 trials Sub-types →
- Middle ear neuroendocrine tumor 0 trials Sub-types →
- Uterine corpus neuroendocrine neoplasm 0 trials Sub-types →
-
Thyroid tumor 36 trials · 366 incl. sub-types
5 sub-types
- Thyroid cancer 166 trials · 328 incl. sub-types Sub-types →
- Benign thyroid gland neoplasm 21 trials · 26 incl. sub-types Sub-types →
- TSH producing pituitary tumor 0 trials · 2 incl. sub-types Sub-types →
- Familial thyroglossal duct cyst 2 trials
- Thyroid hyalinizing trabecular adenoma 0 trials
-
Thymus neoplasm 5 trials · 240 incl. sub-types
4 sub-types
- Thymus cancer 10 trials · 225 incl. sub-types Sub-types →
- Thymic epithelial neoplasm 14 trials · 56 incl. sub-types Sub-types →
- Thymic neuroendocrine tumor 3 trials · 6 incl. sub-types Sub-types →
- Benign neoplasm of thymus 0 trials Sub-types →
-
Adrenal gland neoplasm 13 trials · 151 incl. sub-types
8 sub-types
- Adrenal cortex neoplasm 11 trials · 63 incl. sub-types Sub-types →
- Adrenal gland cancer 16 trials · 62 incl. sub-types Sub-types →
- Multiple endocrine neoplasia type 1 34 trials
- Cushing disease due to pituitary adenoma 23 trials
- Benign neoplasm of adrenal gland 0 trials · 19 incl. sub-types Sub-types →
- Pheochromocytoma-paraganglioma 18 trials
- Adrenal medulla neoplasm 0 trials · 16 incl. sub-types Sub-types →
- Pituitary dermoid and epidermoid cysts 0 trials
-
Pituitary tumor 23 trials · 83 incl. sub-types
9 sub-types
- Pituitary gland adenoma 34 trials · 67 incl. sub-types Sub-types →
- Functioning pituitary gland neoplasm 0 trials · 24 incl. sub-types Sub-types →
- Prolactin producing pituitary tumor 2 trials · 11 incl. sub-types Sub-types →
- Non-functioning pituitary gland neoplasm 0 trials · 9 incl. sub-types Sub-types →
- Growth hormone-producing pituitary gland neoplasm 0 trials · 5 incl. sub-types Sub-types →
- Pituitary cancer 2 trials · 4 incl. sub-types Sub-types →
- ACTH-producing pituitary gland neoplasm 1 trial Sub-types →
- Benign neoplasm of pituitary gland 0 trials
- Posterior pituitary gland neoplasm 0 trials Sub-types →
-
Benign endocrine neoplasm 0 trials · 60 incl. sub-types
14 sub-types
- Benign thyroid gland neoplasm 21 trials · 26 incl. sub-types Sub-types →
- Benign neoplasm of adrenal gland 0 trials · 19 incl. sub-types Sub-types →
- Benign neoplasm of parathyroid gland 0 trials · 6 incl. sub-types Sub-types →
- Liver hemangioma 6 trials Sub-types →
- Hepatocellular adenoma 2 trials Sub-types →
- Pineocytoma 1 trial
- MAX-related tumor predisposition 0 trials
- TMEM127-related tumor predisposition 0 trials
- Benign carotid body paraganglioma 0 trials
- Benign neoplasm of pituitary gland 0 trials
- Benign neoplasm of thymus 0 trials Sub-types →
- Bile duct papillary neoplasm 0 trials Sub-types →
- Liver leiomyoma 0 trials Sub-types →
- Liver lipoma 0 trials Sub-types →
-
Tumor of parathyroid gland 3 trials · 46 incl. sub-types
3 sub-types
- Familial primary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Benign neoplasm of parathyroid gland 0 trials · 6 incl. sub-types Sub-types →
- Malignant tumor of parathyroid gland 2 trials · 6 incl. sub-types Sub-types →
-
Functioning endocrine neoplasm 0 trials · 38 incl. sub-types
2 sub-types
- Functioning pituitary gland neoplasm 0 trials · 24 incl. sub-types Sub-types →
- Functional pancreatic neuroendocrine tumor 1 trial · 14 incl. sub-types Sub-types →
-
Pineal body neoplasm 4 trials · 22 incl. sub-types
5 sub-types
- Pineal gland cancer 0 trials · 19 incl. sub-types Sub-types →
- Pineal parenchymal cell neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Pineal region teratoma 0 trials · 1 incl. sub-types Sub-types →
- Papillary tumor of the pineal region 0 trials
- Pineal region meningioma 0 trials
-
Non-functioning endocrine neoplasm 0 trials · 16 incl. sub-types
3 sub-types
- Non-functioning pituitary gland neoplasm 0 trials · 9 incl. sub-types Sub-types →
- Non-functional pancreatic neuroendocrine tumor 4 trials Sub-types →
- Non-functioning adrenal cortex adenoma 3 trials
-
Granulosa cell tumor 2 trials · 6 incl. sub-types
2 sub-types
- Ovarian granulosa cell tumor 2 trials · 5 incl. sub-types Sub-types →
- Testicular granulosa cell tumor 0 trials Sub-types →
-
Familial tumoral calcinosis 1 trial
5 sub-types
- Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome 0 trials
- Normophosphatemic familial tumoral calcinosis 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 1 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 2 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 3 0 trials
Most studied deeper sub-types
-
Engineered immune cells take on metastatic tumors in new trial
Disease control Recruiting nowThis phase 2 trial tests whether a patient's own white blood cells, genetically modified in a lab to recognize and attack their specific tumor mutations, can shrink metastatic cancers. Participants include people with several advanced solid tumors or multiple myeloma who have exh…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New PET tracer aims to reveal hidden inflammation in cancer patients
Diagnosis Recruiting nowThis early-stage study tests a new imaging agent called 18F-4FN for PET scans to safely detect inflammation in the body. It involves 55 adults with cancer who are on immunotherapy or have suspected inflammation. The goal is to see if this agent can highlight areas of inflammation…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
Scientists dive deep into endocrine tumors to unlock molecular secrets
Knowledge-focused Recruiting nowThis study enrolls people with endocrine tumors (such as thyroid, parathyroid, adrenal, or pancreatic tumors) who are scheduled for surgery or biopsy. Researchers collect samples of the tumor, nearby healthy tissue, blood, and urine to analyze genetic and molecular changes. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists launch massive tumor repository to unlock cancer secrets
Knowledge-focused Recruiting nowThis study collects extra blood, urine, and tumor samples from children and adults with certain cancers to build a large tissue repository. Researchers will analyze these samples to learn more about the genetic and molecular makeup of these tumors. The goal is to support future s…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Dietary change explored as cancer support strategy
Knowledge-focused Recruiting nowThis early-stage study tests whether people with advanced solid tumors can safely follow a diet low in methionine, an amino acid found in many proteins. Researchers will measure how well participants stick to the diet, check for side effects, and track changes in blood methionine…
Early phase 1 • Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC